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ABSTRACT We report that endogenous regulatory fac-
tors mediating expression of a lineage-specific sea urchin
embryo gene can be titrated in vivo by introduction of a
sufficient molar excess ofDNA-binding sites. Thus we obtain an
estimate of the quantity of limiting factor(s) required for
developmental activation and transcriptional expression,
which can be compared with estimates of factor prevalence
obtained by measurements in vitro carried out under equilib-
rium conditions. A fusion construct in which the bacterial gene
for chloramphenicol acetyltransferase (CAT; acetyl-CoA:chlor-
amphenicol 03-acetyltransferase, EC 2.3.1.28) is controlled by
cis-regulatory elements of the CyIlla cytoskeletal actin gene
(CyllIa-CAT) was introduced in varying numbers of copies into
sea urchin eggs. The activity of the Cyflia-CAT fusion gene in
24-hr blastula-stage embryos was shown to saturate as the
number ofexogenous genes was increased. The mean number of
Cyllla-CAT fusion genes per nucleus at which half saturation
was obtained was 105 ± 40 (mean ± SD). This result suggests
that equilibrium parameters measured earlier in vitro may
apply, at least approximately, within the embryo nuclei.
The CyIIIa cytoskeletal actin gene of Strongylocentrotus
purpuratus (1, 2) provides a marker of the process of
differential gene expression by which the embryo constructs
its initial sets of specialized cell lineages. The gene is
transcriptionally activated 10-12 hr postfertilization (3-5)
and is expressed throughout embryonic development, exclu-
sively in the six cell lineages from which derive the aboral
ectoderm of the completed pluteus (6-8). A fusion construct
consisting of the chloramphenicol acetyltransferase (CAT;
acetyl-CoA:chloramphenicol 03-acetyltransferase, EC
2.3.1.28) reporter gene under the control of upstream CyIIIa
sequences (CyIIIa-CAT fusion gene) has been microinjected
into unfertilized eggs (9). A regulatory domain that includes
necessary and sufficient cis-acting sites to promote CAT
expression on the correct developmental schedule (10), and
exclusively in cells of the correct lineages (11, 12), can thus
be identified. The CyIIIa regulatory domain extends for
about 2.5 kilobases (kb) upstream ofthe locus oftranscription
initiation (refs. 3 and 10; F. Calzone, N. Thez6, and E.H.D.,
unpublished data). Reactions carried out in vitro with probes
spanning this region demonstrate at least 11 different se-
quence-specific interactions with DNA-binding proteins pres-
ent in extracts from nuclei of blastula-stage embryos in which
the CyIlIa gene is active (ref. 13; N. Thdzd, F. Calzone, and
E.H.D., unpublished data). The stoichiometry of DNA-
protein complex formation in these extracts provides esti-
mates of the equilibrium parameters that govern these inter-
actions in vitro and also of the approximate minimum
prevalences in the blastula nuclear extracts for each of the
respective DNA-binding factors (13-15). The biological sig-
nificance of several of these specific interactions is indicated
by additional gene transfer experiments in which excess
quantities of individual subfragments of the regulatory do-
main were coinjected with the complete Cylla-CAT fusion
construct (R. Franks, R. Anderson, B. Hough-Evans, and
E.H.D., unpublished data). Thus competition by certain
subfragments that include particular interaction sites identi-
fied in vitro severely depresses CAT expression in transgenic
embryos and, in at least one case, appears to affect spatial
regulation as well. To summarize, current evidence supports
the conclusion that some of the DNA-protein interactions
observed in vitro constitute the casual events that produce
the temporal and spatial regulation of the CyIIIa gene.
The present work was undertaken to obtain estimates of
the available concentration of the limiting factor(s) in vivo.
We have varied the number of Cylla-CAT fusion genes
stably incorporated per embryo nucleus and have measured
the consequent output of CAT enzyme. We first show that,
as implied by our earlier study (10), the regulatory system is
effectively saturated when about 1500 copies of the CyIIIa-
CATgene are injected per egg. Thus CAT enzyme production
in blastula-stage embryos raised from these eggs is almost
stoichiometrically decreased by coinjection of various
amounts of the upstream CyIIIa regulatory domain. We then
report measurements of CAT enzyme production as a func-
tion of the number of copies of the Cyllia-CAT gene
incorporated for several different batches of eggs. These
measurements demonstrate the, saturation behavior of the
limiting factor(s) in vivo and thus provide an approximate
estimate of the number of such factor molecules available per
nucleus. Finally, we compare this estimate with those ob-
tained previously from in vitro measurements of factor
prevalence in crude nuclear extracts of embryos expressing
the CyIIIa gene (13).
MATERIALS AND METHODS
Micro'N ection of Eggs with Carrier and Competitor DNA
Solutions. S. purpuratus eggs were microinjected and subse-
quently cultured as previously described (9, 10). The aggre-
gate concentration of the injected DNAs was held constant
within each experiment, at about 56 ,ug/ml. Sperm DNA
prepared as previously described (1) was used as carrier.
About 200 gg ofDNA was digested with Sph I, concentrated
by 1-butanol extraction, and loaded onto two preformed 10-
40% sucrose step gradients in 1 M NaCl/20 mM Tris, pH 8/5
mM EDTA. The gradients were centrifuged at 20'C in an
SW41 rotor at 28,000 rpm for 16 hr. Each gradient was
divided into '20 fractions. Ten microliters was removed
from each fraction; size analysis was performed by gel
electrophoresis; and fractions containing fragments larger
than 5 kb were pooled, dialyzed against 10 mM Tris, pH 8/0.1
mM EDTA, reconcentrated by 1-butanol extraction, and
Abbreviation: CAT, chloramphenicol acetyltransferase.
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precipitated. This protocol yielded carrier DNA with Sph I
termini and with an average length of -10 kb, [i.e., only
slightly below the length of the CyIIIa-CATconstruct utilized
(14 kb)]. The fragments of the CyIIIa-CAT used for compe-
tition experiments were prepared by digestion with the
appropriate restriction enzyme, as indicated, followed by
separation by electrophoresis through an 0.8% agarose gel
and purified by elution from DE81 filters.
Other Procedures. All other procedures were carried out as
previously described (10).
RESULTS
Near-Stoichiometric Competition in Vivo by Cyllia Regula-
tory Sequences at a Saturating Level of Cyllla-CAT Genes. The
study of Flytzanis et al. (10) demonstrated that a more or less
constant amount of CAT enzyme is produced by embryos
raised from eggs injected with various quantities of CyllIa-
CAT DNA, ranging from a few hundred to thousands of
molecules per egg. It was proposed that within this range the
number of copies of the CyIlla regulatory sequence incorpo-
rated is probably saturating for regulatory factors available at
limited concentrations within the blastula nuclei (10). Linear
DNA molecules injected into sea urchin egg cytoplasm are
rapidly ligated into end-to-end concatenates, irrespective of
the terminal sequences. In most embryos, these are stably
incorporated into one or a few blastomere nuclei after the third
to fifth cleavage, which results in a mosaic pattern of exoge-
nous DNA retention that is apparently random with respect to
embryonic cell lineage (9, 10, 12, 16, 17). After incorporation,
the exogenous DNA replicates at approximately the rate of the
genomes of the host cells. Significant loss of DNA does not
occur during embryogenesis. Thus, if several thousand mol-
ecules of DNA are injected into the unfertilized egg, this
number of copies of the injected sequence may be stably
retained in all the cells descendant from the blastomere(s) in
which the initial incorporation event took place.
If the amount ofCAT expression in such embryos is indeed
limited by regulatory factor availability and the CylI~a-CAT
genes are present in excess, then coinjection of additional
copies of the upstream CyIla regulatory domain together
with the complete CyIIIa-CAT reporter fusion construct
should competitively reduce CAT enzyme expression. Fur-
thermore, competition should occur at relatively low molar
ratios of competitor to CyIIla-CAT sequence, and the
amount of competition should stoichiometrically reflect the
incorporated competitor/fusion gene ratios. To explore these
predicted consequences experimentally, we injected eggs with
1500 molecules of the CyIIa-CAT fusion gene, together with
varying numbers of molecules of subfragments containing the
whole Cy~lla regulatory domain. Linearized carrier DNA
terminating in Sph I ends, as does the linearized CyIlIa-CAT
construct, were coinjected in quantities adjusted so that the
total mass of injected DNA remained constant at 0.1 pg. Fig.
la shows the restriction map of the CyIIIa-CAT gene and the
locations oftwo different fragments that include the regulatory
domain and that were used alternatively as competitor
(namely, a 9.3-kb Sal I fragment and a 2.7-kb Sph I-BamHI
fragment). The 9.3-kb Sal I fragment contains the entire 5'
flanking region and the 5' transcribed leader associated with
the CylIla-CAT gene. The 2.7-kb Sph I-BamHI fragment
contains the most proximal 2.5 kb of 5' flanking sequence as
well as the origin o0 Cyflla transcription and about 200 bp of
5' transcribed leader. All known sites of interaction between
nuclear factors and the CyIIa upstream sequence and all
known regions that in functional tests are of regulatory
significance are included between the Sph I and BamHI sites
(refs. 10 and 13; R. Franks and E.H.D., unpublished data; see
Fig. la). The results of these experiments are summarized in
Fig. lb, in which the average number of CAT enzyme
molecules produced per embryo is given as a function of the
molar ratio of competitor to CyIlIa-CAT genes injected (e.g.,
for the ratio of 5, 7500 molecules of the Sph I-BamHI fragment
were coinjected with 1500 molecules of the CyIla-CAT gene,
together with about 6200 molecules of carrier DNA). Note that
the two different 5' CyIIIa gene fragments used compete
similarly despite their >3-fold difference in length and the fact
that the 2.7-kb Sph I-BamHI fragment has a terminus homol-
ogous with the CyIIIa-CAT DNA termini (and the carrier
DNA termini), whereas the 9.3-kb fragment does not. The
dashed line in Fig. lb shows the ideal results that would have
been obtained had reduction in CAT activity occurred with
perfect stoichiometry with respect to the number of Cyflla 5'
flanking sequences present. The experimental data fit by the
solid line indicate that the competition behaves as if about 40%o
of the competing DNA were effective, rather than all of it.
There are several possible interpretations, the most likely of
which is that in some embryos of each batch concatenates
containing competing DNA and little or no CyIIa-CATDNA
were formed and incorporated in different cells from the bulk
of the CyllIa-CAT DNA. It is also possible that for some
reason the competing DNA was marginally less likely to be
engaged in concatenates in the first place. This small differ-
ence from ideal stoichiometry aside, however, Fig. lb pro-
vides clear evidence of systematic competition in vivo, at the
modest competitor/reporter gene ratios expected. Thus, for
example, at a competitor/reporter gene ratio of only 5:1,
activity is reduced to about 30o of the control value. This
behavior requires that the CyIIIa-CAT reporter gene is in fact
close to, if not at, saturation with respect to at least the limiting
intranuclear factor(s) required for CAT expression.
Saturation of CylIla-CAT Expression in Transgenic Em-
bryos. Measurements of CAT expression in samples of 24-hr
embryos bearing increasing numbers of CyIlIIa-CAT genes
were carried out on single batches of eggs. We were aware
from earlier studies (10, 12) that given batches display variable
abilities to concatenate, incorporate, and thence amplify the
injected DNA. The eggs were all injected with a total mass of
about 0.1 pg of DNA. Of this, at least 80% was carrier DNA
(i.e., about 7500 molecules per egg at the nominal 10-kb length
of the carrier preparation), and the remainder consisted of
various amounts of the 14-kb CyIIIa-CAT fusion gene plus
sufficient carrier to achieve the equivalent of 0.1 pg of injected
DNA mass in all samples. Thus individual eggs received from
30 to 1500 copies ofthe CyIIIa-CATconstruct, and all samples
contained at least a 5-fold molar excess ofcarrier. The addition
of a modest molar excess of carrier DNA has been found to
increase CAT expression several fold in embryos bearing the
CyIIIa-CAT fusion, possibly by providing spacers between
adjacent CyIIIa-CAT molecules in the incorporated concate-
nates (ref. 17; R. Franks and E.H.D., unpublished data).
Maximum expression is always attained at the .5-fold molar
excess of carrier DNA/CyIIIa-CAT DNA utilized in these
experiments. The experimental design thus ensures that the
only systematic variable affecting CAT expression will be the
number of incorporated CyIlIa-CAT genes in the various
samples of each experiment. This was calculated from direct
measurements of CAT DNA sequence content in aliquots of
the experimental embryos, obtained by slot blot hybridization
with a CAT sense-strand 32P-labeled RNA probe (see legend
to Fig. 2). CAT enzyme content was also measured in extracts
ofeach sample ofembryos, and the average amount ofenzyme
in the cells producing it (i.e., those aboral ectoderm cells
bearing the exogenous DNA) was calculated. To derive this
value, we applied a measurement recently obtained by Hough-
Evans et al. (12), who found by in situ DNA hybridization that
a mean of 6% of the total cells of 24-hr embryos grown from
eggs cytoplasmically injected with CyIIIa-CAT bear stably
incorporated exogenous DNA concatenates. When the small
fraction of eggs in each sample that received or retained no
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FIG. 1. CyIIIa-CAT fusion gene, competitor DNA fragments, and in vivo competition in transgenic embryos. (a) Map of the CyllIa gene
with the two upstream fragments containing all known CylIIa regulatory elements used as competitor DNAs. Restriction enzyme sites are
indicated as follows: B, BamHI; E, EcoRI; H, Hindi11; N, Nco I; P, Pst I; Sp, Sph I. SV40, simian virus 40. (b) Competition by excess regulatory
DNA fragments decreases CAT production from coinjected CyJIfa-CAT reporter genes. A and A, Experiments with the 10-kb Sal I competitor
fragment. e and o, Experiments with the 2.7-kb Sph I-BamHI competitor fragment. About 1500 molecules ofCyiffa-CAT were injected at each
point together with the indicated number of competitor fragments. The mass ofDNA injected at each point was kept constant by the addition
of varying amounts of sea urchin genomic DNA. Thirty to 90 embryos were pooled and assayed for CAT activity at each point. The. relationship
between CAT activity per embryo relative to the control in which no competitor DNA was included (y) and the molar ratio of competitor DNA
molecules to CyJIfa-CAT genes (x) can be approximated as y = (1 + ax) -1, where a is the fraction of competitor fragments actively functioning
as competitor. Controls in these experiments averaged 5 x 106 CAT enzyme molecules per embryo (cf. refs. 10 and 17). The dashed curve
indicates the ideal form (i.e., when a = 1). A least-squares fit to the experimental data shown yields a value for a of 0.41. Av., Average.
DNA whatsoever, due to unsuccessful injection, is included in
the embryo pools as in this work, the mean fraction of cells in
the total sample bearing the exogenous DNA is about 5%. This
result was independently confirmed for two of the batches of
eggs utilized for the present experiments, which were assayed
by the same in situ DNA hybridization method (data not
shown). Since -200 ofthe cells of the ~=500-cell 24-hr embryo
belong to the aboral ectoderm lineages and are capable of
expressing CyIlla-CAT (6-8, 11, 12), CAT enzyme content
per average expressing cell should be about 1o of the total
CAT enzyme content per 24-hr embryo.
Saturation curves depicting CAT production as the number
of CylIla-CAT genes is increased are shown in Fig. 2a for
two separate batches of eggs obtained from a single S.
purpuratus female. The data are fit to the form
C- , [1]
1 + kCO/G
where C is CAT enzyme activity per cell, G is the number of
Cyilla-CAT genes per cell as calculated from the slot blot
hybridization measurements, CO is the saturation level of
CAT enzyme per cell, and k is a proportionality constant (k
is the inverse of the CAT enzyme output per gene at very
small numbers of genes-i.e., far below saturation). Since it
is impossible to inject enough DNA to achieve truly complete
saturation without incurring lethality in the gene transfer
process (9), the extrapolated saturation (CO) values of the
various experimental series are shown in Fig. 2b as double
inverse plots; i.e., from Eq. 1,
1 1 1-
-C + k -.
C Co G
[2]
Here the saturation values can be obtained from the intercepts
(i.e., 1/Co), and the slopes of the various lines (i.e., k) display
directly the biological variations between different batches of
eggs. Six such experiments (including the two shown in Fig.
2a, namely, experiments 5a and 5b) are coplotted in Fig. 2b,
and the respective least-squares values of k and CO are shown
in Table 1. Here it can be seen that the different batches ofeggs
vary considerably in their ability to produce CAT enzyme
from high numbers of genes and hence in the values of CAT
enzyme molecules per cell at saturation (CO). However, the
variability observed as well as the average of these saturation
values is consistent with the typical CAT enzyme levels
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FIGa- 2. Saturation of CyIIa-CATexpression in different batches
of transgenic S. purpuratus embryos. (a) CAT enzyme (molecules
per embryo) produced by embryos grown from two batches of eggs
obtained from the same female about 1 week apart. Increasing
quantities ofCy~lIa-CATDNA plus carrier DNA, to a constant mass
of 0.1 pg per egg, were injected, and the eggs were fertilized. At 24
hr, the blastulae were harvested. Forty to 80 embryos were analyzed
for each point shown. Cylifa-CAT DNA was measured for each
sample by slot blot hybridization with a CAT sense-strand 32P-
labeled RNA probe, and CAT enzyme activity was assayed and
converted to molecules of CAT enzyme as described (10, 18). Since
concatenation and amplification of exogenous DNA in these em-
bryos occur without reference to the sequence of the DNA (9, 16),
to obtain the range of genes per embryo values shown for each
experiment, it was only necessary to measure the actual CAT
sequence content in samples of those embryos injected with the
largest amounts of CylIIa-CAT DNA. Thus the numbers of CyIIla-
CAT genes per cell shown are calculated for all but the final sample.
The number of CAT DNA sequences in samples raised from eggs
injected with lower Cyilla-CAT DNA/carrier DNA ratios is thus
given by the average amount present in the measured embryos
multiplied by the ratio of the number of CylIa-CAT molecules
injected in eggs of the given sample to that injected in eggs of the
measured (i.e., highest) sample. The CAT enzyme per cell data
points were fit by least-squares analysis to the form of Eq. 1 (solid
lines). For the parameters obtained in these particular experiments
see Table 1, samples Sa and Sb. (b) Double reciprocal plots according
to Eq. 2 of six independent experiments, each carried out with a
single batch of eggs (including the two experiments shown in a).
Procedures were as described in a. Least-squares solutions for each
data set are shown in Table 1.
reported in earlier studies using carrier DNA and near-
saturating quantities of CyIlfa-CAT genes [i.e., taking into
account that CAT enzyme levels per embryo will be about 10
times the CAT per cell values listed in Table 1 (for example,
Table 1. Saturation parameters for CyllIa-CAT expression in
transgenic sea urchins
GO.5,t G0.9,t
k, genes genes genes COj CAT
Female* per CAT per cell per cell per cell (sat.)
1 7.0 x 10-5 88 990 1.25 x 106
2 7.7 x 10-5 70 620 9.1 x 105
3 1.8 x 1o-4 82 760 4.5 x 105
4 1.9 x 10-4 158 1860 8.3 x 105
5a 5.4 x 10- 79 700 1.45 x 106
Sb 2.6 x 1O-4 153 1400 5.9 x 105
Mean ± SD 1.4 x 1O-4 105 1055 1.1 X 106
+8.3 x 1Q-5 ±40 ±480 +4.4 x 105
CAT, CAT enzyme molecules; sat., saturation.
*Each batch of eggs was obtained from a different female except for
5a and Sb, which both derived from the same female. The batches of
eggs (female number) correspond to the experiments in Fig. 2a. See
Figs. 1 and 2 and Materials and Methods for experimental details.
tG05. and G0.9 represent genes per cell (average) for 50o and 90%
saturation, respectively, given the least-squares solutions for CO and
k and assuming Eq. I.
tParameters derived from linear least-squares reductions of the data
shown assuming Eq. 2.
refs. 12 and 17)]. Table 1 shows that the half-saturating number
of CyIIIa-CAT sequences per cell (Go.5) is 105 + 40 genes(mean + SD). The variation in these data is little greater than
the variation between the two sibling experiments shown in
Fig. 2a (experiments 5a and Sb). The excellent fit of the data
for all batches to the form of Eq. 1 or 2 demonstrates that as
the number ofCyIIIa-CATgenes per cell increases, the output
of CAT enzyme indeed follows saturation behavior, and thus
the incorporated genes can be considered to be titrating out
cellular factor(s) needed to express this sequence. Since 50%
saturation is approached at only about 102 genes per cell,
whereas the same cells are probably expressing at least 1-2 x
104 diverse transcription units (18), it is obvious that the
saturation observed is a phenomenon that pertains to CylIla
or a small class of genes that might require the same factors.
It follows that the saturation functions shown in Fig. 2
represent titrations of a limiting set of sequence-specific
factors required for Cyilla expression.
DISCUSSION
The titration described here provides an absolute index ofthe
molecular availability of the limiting factors required for
CyIlla-CAT expression. We assume in the following that
these are sequence-specific transcription factors, since the
coinjected upstream regulatory sequences of the Cyl~la gene
compete efficiently with the CylIIa-CATfusion gene. Similar
results were obtained from other unpublished experiments
(cited in the Introduction) in which small subfragments of the
upstream sequence that include no transcribed or translated
sequence whatsoever were coinjected. However, there is no
formal proof that the results of the titration experiments are
not affected by competition for specific, rare, translation
factors, a possibility that we nonetheless discard on grounds
of improbability. The efficient competition shown in Fig. 1
obviously cannot be explained on this basis since all samples
contain the same amount of translatable sequence. Compe-
tition for general translation as well as transcription factors is
precluded because the CAT transcripts are only a few percent
of the total nuclear transcripts and, similarly, because CAT
protein translation per se represents only a few percent ofthe
total embryo protein synthesis. Thus Flytzanis et al. (10)
calculated that the half-life of CAT enzyme in sea urchin
embryos is about 40 min, and, from this and the maximum
steady-state levels ofCAT enzyme per cell shown in Table 1,
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the synthesis rate should be about 1.9 x 104 CAT enzyme
molecules per min per cell. This may be compared to about
2 x 105 protein molecules synthesized per min per cell in late
blastula-stage sea urchin embryos, by assuming the poly-
somal mRNA contents and translation rates measured for S.
purpuratus embryos (18).
By assuming then that the titrations we report measure the
number of bound regulatory factors of the limiting species per
nucleus in vivo, we proceed to a comparison with the results
of DNA-protein binding studies carried out in vitro with the
same CyIIIa regulatory domain (13). We adopt the G0o9 values
of Table 1 (on the basis that one protein molecule of a given
limiting species binds per site) as an approximate index of the
minimum number of factor molecules available for binding
within the aboral ectoderm nuclei. That is, we assume that
about 1055 sites per nucleus bind 90%o ofthe available factor(s)
ofthe limiting species, since this number of specific exogenous
incorporated sites results in 90%o of the possible gene expres-
sion. The number of these factors per embryo must then be at
least 2.1 x 10', since there are 200 aboral ectoderm cells, and
this could be up to a 2.5-fold underestimate, as the factors in
question might be present in other cells as well. However,
there are also factor molecules that would be unavailable
because they are at any one moment bound to some ofthe huge
number of nonspecific DNA sites present in the nuclear
genome. As an extreme estimate of these, we consider the
total internucleosomal DNA, or about 30o of the nucleotide
pairs in the genome. For the CyIIIa regulatory factors,
Calzone et al. (13) measured binding preferences, orKr values,
for specific as compared to nonspecific DNA sites that ranged
from about 3 x 104 to about 2 x 106 (Kr = KS/Kfl, where K,
and Kn are, respectively, the equilibrium constants for the
specific and nonspecific reactions of the binding proteins; ref.
15). The ratio of the amount offactor bound to nonspecific vs.
specific sites is, from the definition of the equilibrium con-
stants, given by Dn/KDs, where Dn is the concentration of
nonspecific sites in the nucleus and Ds is the concentration of
specific sites. Here D. is the molar concentration of30o of 1.6
x 109 nucleotide pairs in the diploid nucleus, and D. is the
molar concentration of the 1055 specific sites at 90%o satura-
tion. Thus for the range of Kr values observed in vitro, most
of which fall between 5 x 10' and 106, 90%o and 50%,
respectively, of the factor(s) would be found associated with
the nonspecific sites, were equilibrium conditions to prevail.
For example were Kr = 106, the total number of factor
molecules of that species would be about 2100 per nucleus, of
which half (1055) are bound to specific and half to nonspecific
sites. However, the total amount of available nonspecific
DNA per nucleus is most probably much less than 30%o of the
total base pairs in the diploid genome (14, 15), and thus the
fraction offactor molecules bound to nonspecific DNA will in
actuality be less. In any case, this heuristic argument shows
that the amount of factor per nucleus should fall within a few
fold of the total number of sites actually bound per nucleus as
the saturation curves in our experiments approach their
maximum. Our previous measurements offactor prevalence in
nuclear extracts in vitro (13) yielded an average, for 11
different CyIIa regulatory interactions studied, of about 3.2
x 103 molecules of factor per nucleus, by assuming distribu-
tion to 200 cells per embryo. This value seems unexpectedly
similar to the value we estimate here from in vivo saturation
measurements.
This result implies that DNA-binding factor prevalences,
measured in vitro for DNA-protein interactions at equilib-
rium, may be referred to regulatory binding interactions in life.
The general implication, which remains to be directly tested,
is that the concentrations of bound and free regulatory sites
and nonspecific sites are all at equilibrium within the nucleus.
Our experiments show that there is no very large reservoir of
extractable binding factor irreversibly associated with non-
specific sites (i.e., beyond those factor molecules that can be
stolen from nonspecific sites as high-affinity sites are added).
Calzone et al. (13) estimated a half-life for the protein-
nonspecific DNA complexes bound by the CyIlla factors in
vitro of the order of a few milliseconds, and these complexes
must be highly unstable in vivo as well. Thus, it is reasonable
to conclude that the Kr values in vivo are not greatly lower than
those we measured in vitro. They could be higher, however,
and thus it is not yet clear whether once formed the specific
DNA-protein complexes in vivo are also as unstable as
observed in vitro. As measured in the crude nuclear extracts,
the half-lives of these ranged from several minutes to close to
an hour, and on present evidence it cannot be excluded that in
living nuclei such complexes are "locked" into more stable
configurations. However, the results we report permit the
possibility that the specific as well as the nonspecific interac-
tions within the nucleus behave more or less as expected from
equilibrium considerations in vitro. The active state of a gene
would thus be maintained by the continuous presence of a
sufficient reservoir of binding factors, rather than by persis-
tence of nondissociable complexes. Any given active gene at
any given moment might be disengaged from its regulatory
factors and re-engaged the next moment and, thus, with
respect to dissociation of active complexes, DNA replication
might not be a particularly unique event. In an equilibrium
system, control would be dynamic rather than exclusively
structural, and the cessation or quantitative modulation of
activity might be governed, with a brief time lag dependent
only on complex half-life, by an increase or decrease in the
ambient concentration of active factor.
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